General practitioner perceptions of clinical medication reviews undertaken by community pharmacists

Journal of Primary Health Care

Volumn 2, Issue 3, 2010, Pages 225-233

  Bryant, Linda ^a   Coster, Gregor ^a   McCormick, Ross ^a  

^a UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Community pharmacy services; Drug utilization review; Family physicians; Health plan implementation; Interprofessional relations; Primary healthcare; Qualitative research

Indexed keywords

ADULT; ARTICLE; DRUG USE; FEMALE; GENERAL PRACTITIONER; HEALTH PERSONNEL ATTITUDE; HUMAN; INTERVIEW; MALE; MIDDLE AGED; PHARMACY; PROFESSIONAL STANDARD; PUBLIC RELATIONS;

ADULT; ATTITUDE OF HEALTH PERSONNEL; COMMUNITY PHARMACY SERVICES; DRUG UTILIZATION REVIEW; FEMALE; GENERAL PRACTITIONERS; HUMANS; INTERPROFESSIONAL RELATIONS; INTERVIEWS AS TOPIC; MALE; MIDDLE AGED; PROFESSIONAL ROLE;

EID: 79952109037     PISSN: 11726164     EISSN: 11726156     Source Type: Journal    
DOI: 10.1071/hc10225     Document Type: Article

References (25)

1. Norris P. The negotiation and re-negotiation of occupational control. A study of retail pharmacy in New Zealand. 1930-1990. A PhD(Sociology) thesis submitted to the Victoria University of Wellington. Wellington: Victoria University; 1993.
2. Harding G, Taylor KM. Professional relationships between general practitioners and pharmacists in health centres. Br J Gen Pract. 1990;40(340):464-6.
3. Smith WE, Ray MD, Shannon DM. Physicians' expectations of pharmacists. Am J Health-Syst Pharm. 2002;59(1):50-7.
4. Bleiker P, Lewis A. Extending the role of community pharmacists: The views of GPs. Int J Pharm Pract. 1998;6(3):140-144.
5. Sulick JA, Pathak DS. The perceived influence of clinical pharmacy services on physician prescribing behavior: a matched-pair comparison of pharmacists and physicians. Pharmacotherapy. 1996;16(6):1133-41.
6. Ritchey FJ, Raney MR. Effect of exposure on physicians' attitudes toward clinical pharmacists. Am J Hosp Pharm. 1981;38(10):1459-63.
7. Hughes C, McCann S. Perceived interprofessional barriers between community pharmacists and general practitioners: a qualitative assessment. Br J Gen Pract. 2003;53:600-06.
8. Edmunds J, Calnan MW. The reprofessionalisation of community pharmacy? An exploration of attitudes to extended roles for community pharmacists amongst pharmacists and general practitioners in the United Kingdom. Soc Sci Med. 2001;53(7):943-55.
9. Ambler S. General practitioners and community pharmacists: times they are a-changing. Br J Gen Pract. 2003;53:594-95.
10. Campbell Research & Consulting. Home Medicines Review Program qualitative research project. Final report. http://www.health.gov.au/internet/main/publishing.nsf/Content/B2992EBF12BE7E1ECA2573D8007F91F3/$File/HMR%20Final%20Report.pdf. Canberra, ACT, Australia: Prepared for the Department of Health and Ageing; Dec 2008.
11. Ellis SL, Carter BL, Malone DC, Billups SJ, Okano GJ, Valuck RJ, et al. Clinical and economic impact of ambulatory care clinical pharmacists in management of dyslipidemia in older adults: the IMPROVE study. Impact of Managed Pharmaceutical Care on Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000;20(12):1508-16.
12. Malone DC, Carter BL, Billups SJ, Valuck RJ, Barnette DJ, Sintek CD, et al. An economic analysis of a randomized, controlled, multicenter study of clinical pharmacist interventions for high-risk veterans: the IMPROVE study. Impact of Managed Pharmaceutical Care Resource Utilization and Outcomes in Veterans Affairs Medical Centers. Pharmacotherapy. 2000;20(10):1149-58.
13. Rothman RL, Malone R, Bryant B, Shintani AK, Crigler B, Dewalt DA, et al. A randomized trial of a primary care-based disease management program to improve cardiovascular risk factors and glycated hemoglobin levels in patients with diabetes. Am J Med. 2005;118(3):276-84.
14. Shojania KG, Ranji SR, McDonald KM, Grimshaw JM, Sundaram V, Rushakoff RJ, et al. Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis. JAMA. 2006;296:427-40.
15. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001;323(7325):1340-3.
16. Reebye RN, Avery AJ, Bissell P, Van Weel C. The issue of territoriality between pharmacists and physicians in primary care. Int J Pharm Pract. 2002;10(2):69-75.
17. Adamcik BA, Ransford HE, Oppenheimer PR, Brown JF, Eagan PA, Weissman FG. New clinical roles for pharmacists: a study of role expansion. Soc Sci Med. 1986;23(11):1187-1200.
18. Holland R, Battersby J, Harvey I, Lenaghan E, Smith J, Hay L. Systematic review of multidisciplinary interventions in heart failure. Heart. 2005;91(7):899-906.
19. Holland R, Brooksby I, Lenaghan E, Ashton K, Hay L, Smith R, et al. Effectiveness of visits from community pharmacists for patients with heart failure: HeartMed randomised controlled trial. BMJ. 2007. DOI:10.1136/bmj.39164.568183. AE (published 23 April 2007).
20. Holland R, Lenaghan E, Harvey I, Smith RB, Shepstone L, Lipp A, et al. Does home based medication review keep older people out of hospital? The HOMER randomised controlled trial. BMJ. 2005;330:293-97.
21. Carter BL, Chrischilles E, Scales CJ, Hayase N, Bell N. Extent of services provided by pharmacists in the Iowa Medicaid Pharmaceutical Case Management Program. J Am Pharm Assoc. 2003;43:24-33.
22. Community Pharmacy Medicines Management Programme Evaluation Team. The MEDMANstudy: a randomised controlled trial of community pharmacist-led medication management for patients with coronary heart disease. Fam Pract. 2007;24(2):189-200.
23. RESPECT Trial Team. Effectiveness of shared pharmaceutical care for older patients: RESPECT trial findings. Br J Gen Pract. 2010;60(570):10-19.
24. Zermansky AG, Petty DR, Raynor DK, Freemantle N, Vail A, Lowe CJ. Randomised controlled trial of clinical medication review by a pharmacist of elderly patients receiving repeat prescriptions in general practice. BMJ. 2001;323(7325):1340-3.
25. Merenich J, Olson KL, Delate T, Rasmussen J, Helling DK, Ward D. Mortality reduction benefits in a comprehensive cardiac care program for patients with occlusive coronary artery disease. Pharmacotherapy. 2007;27(10):1370-78.